Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 22, 2018

DrugPatentWatch Database Preview

Ergot Derivative Drug Class List

« Back to Dashboard

Drugs in Drug Class: Ergot Derivative

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	BROMOCRIPTINE MESYLATE	bromocriptine mesylate	TABLET;ORAL	076962-001	Sep 24, 2004	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Paddock Llc	BROMOCRIPTINE MESYLATE	bromocriptine mesylate	TABLET;ORAL	077646-001	Oct 1, 2008	AB	RX	No	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Mylan	BROMOCRIPTINE MESYLATE	bromocriptine mesylate	CAPSULE;ORAL	077226-001	Apr 4, 2005	AB	RX	No	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Zydus Pharms Usa Inc	BROMOCRIPTINE MESYLATE	bromocriptine mesylate	CAPSULE;ORAL	078899-001	Jul 30, 2008	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck

Cipla

Colorcon

Cerilliant

Chubb

Accenture

Julphar

US Army

Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.